JP2009512422A5 - - Google Patents

Download PDF

Info

Publication number
JP2009512422A5
JP2009512422A5 JP2008529347A JP2008529347A JP2009512422A5 JP 2009512422 A5 JP2009512422 A5 JP 2009512422A5 JP 2008529347 A JP2008529347 A JP 2008529347A JP 2008529347 A JP2008529347 A JP 2008529347A JP 2009512422 A5 JP2009512422 A5 JP 2009512422A5
Authority
JP
Japan
Prior art keywords
hydroxycholesterol
differentiation
acetate
4beta
diol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008529347A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009512422A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/034374 external-priority patent/WO2007028101A2/en
Publication of JP2009512422A publication Critical patent/JP2009512422A/ja
Publication of JP2009512422A5 publication Critical patent/JP2009512422A5/ja
Pending legal-status Critical Current

Links

JP2008529347A 2005-09-02 2006-09-05 骨形成及び抗脂肪細胞形成オキシステロール類 Pending JP2009512422A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71406305P 2005-09-02 2005-09-02
PCT/US2006/034374 WO2007028101A2 (en) 2005-09-02 2006-09-05 Osteogenic and anti-adiogenic oxysterols

Publications (2)

Publication Number Publication Date
JP2009512422A JP2009512422A (ja) 2009-03-26
JP2009512422A5 true JP2009512422A5 (https=) 2009-11-05

Family

ID=37809619

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008529347A Pending JP2009512422A (ja) 2005-09-02 2006-09-05 骨形成及び抗脂肪細胞形成オキシステロール類

Country Status (6)

Country Link
US (1) US20090220562A1 (https=)
EP (1) EP1931353A4 (https=)
JP (1) JP2009512422A (https=)
AU (1) AU2006284650A1 (https=)
CA (1) CA2621157A1 (https=)
WO (1) WO2007028101A2 (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7897588B2 (en) 2002-08-29 2011-03-01 The Regents Of The University Of California Agents and methods for enhancing bone formation
US9532994B2 (en) 2003-08-29 2017-01-03 The Regents Of The University Of California Agents and methods for enhancing bone formation by oxysterols in combination with bone morphogenic proteins
US9670244B2 (en) 2006-02-27 2017-06-06 The Regents Of The University Of California Oxysterol compounds and the hedgehog pathway
AU2007339325A1 (en) 2006-12-19 2008-07-10 The Regents Of The University Of California Inhibition of PPAR gamma expression by specific osteogenic oxysterols
US20100112030A1 (en) * 2007-03-16 2010-05-06 The Regents Of The University Of California Role of hedgehog signaling in atherosclerosis and cardiovascular disease
WO2009073186A1 (en) * 2007-12-03 2009-06-11 The Regents Of The University Of California Oxsterols for activation of hedgehog signaling, osteoinduction, antiadipogenesis, and wnt signaling
KR20150013232A (ko) 2012-05-07 2015-02-04 더 리전트 오브 더 유니버시티 오브 캘리포니아 골형성 및 헤지호그 신호전달을 유도하고 지방생성을 억제하는 옥시스테롤 유사체 oxy133
CN105263500A (zh) 2013-05-02 2016-01-20 加利福尼亚大学董事会 骨选择性成骨性氧固醇-骨靶向剂
US9657052B2 (en) 2014-12-09 2017-05-23 Warsaw Orthopedic, Inc. Compounds and methods of making sterols using diols
US9877836B2 (en) 2015-07-10 2018-01-30 Warsaw Orthopedic, Inc. Compression resistant implants including an oxysterol and methods of use
US9987289B2 (en) 2015-07-10 2018-06-05 Warsaw Orthopedic, Inc. Slow release oxysterols and methods of use
US10632230B2 (en) 2015-07-10 2020-04-28 Warsaw Orthopedic, Inc. Implants having a high drug load of an oxysterol and methods of use
US9878070B2 (en) 2015-06-17 2018-01-30 Warsaw Orthopedic, Inc. Malleable implants including an oxysterol and methods of use
US12171909B2 (en) 2015-07-10 2024-12-24 Warsaw Orthopedic, Inc. Implants having a drug load of an oxysterol and methods of use
US9637514B1 (en) 2015-10-26 2017-05-02 MAX BioPharma, Inc. Oxysterols and hedgehog signaling
ITUA20162556A1 (it) * 2016-04-13 2017-10-13 Massimo Dominici Metodo per analizzare le potenzialita' di cellule staminali/stromali mesenchimali nella rigenerazione tessutale
US11384114B2 (en) 2016-12-09 2022-07-12 Warsaw Orthopedic, Inc. Polymorphic forms of an oxysterol and methods of making them
US10434106B2 (en) 2017-05-19 2019-10-08 Warsaw Orthopedic, Inc. Oxysterol-statin compounds for bone growth
US11464888B2 (en) 2017-06-12 2022-10-11 Warsaw Orthopedic, Inc. Moldable formulations containing an oxysterol in an acellular tissue matrix

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3887545A (en) * 1973-11-12 1975-06-03 Hoffmann La Roche Synthesis of 1{60 -hydroxylated cholesterol derivatives
US4183852A (en) * 1977-07-18 1980-01-15 Kaiser Emil T Process for preparing 25-hydroxycholesterol
US4743597A (en) * 1986-01-27 1988-05-10 Javitt Norman B Composition comprising an oxygenated cholesterol and use thereof for topical treatment of diseases
US6893830B1 (en) * 1996-09-27 2005-05-17 The Board Of Regents Of The University Of Texas System Method of screening oxysterol activation of LXRα
US6080779A (en) * 1996-12-13 2000-06-27 Osteoscreen, Inc. Compositions and methods for stimulating bone growth
WO1998032444A1 (en) * 1997-01-24 1998-07-30 The Regents Of The University Of California USE OF FXR, PPARα AND LXRα ACTIVATORS TO RESTORE BARRIER FUNCTION, PROMOTE EPIDERMAL DIFFERENTIATION AND INHIBIT PROLIFERATION
US5929062A (en) * 1997-06-19 1999-07-27 University Of Western Ontario Oxysterol inhibition of dietary cholesterol uptake
WO1999000117A2 (en) * 1997-06-27 1999-01-07 Ontogeny, Inc. Neuroprotective methods and reagents
US20030153541A1 (en) * 1997-10-31 2003-08-14 Robert Dudley Novel anticholesterol compositions and method for using same
US6586189B2 (en) * 1999-06-18 2003-07-01 City Of Hope Screening method for PPAR-γ ligands
US20020161026A1 (en) * 2000-11-07 2002-10-31 Paralkar Vishwas M. Combination therapies for the stimulation of bone growth
US7897588B2 (en) * 2002-08-29 2011-03-01 The Regents Of The University Of California Agents and methods for enhancing bone formation
CA2534567A1 (en) * 2003-08-18 2005-03-03 Wyeth Novel human lxr alpha variants
US9532994B2 (en) * 2003-08-29 2017-01-03 The Regents Of The University Of California Agents and methods for enhancing bone formation by oxysterols in combination with bone morphogenic proteins
US20090202660A1 (en) * 2005-04-07 2009-08-13 The Regents Of The University Of California Agents and Methods for Osteogenic Oxysterols Inhibition of Oxidative Stress on Osteogenic Cellular Differentiation
US9670244B2 (en) * 2006-02-27 2017-06-06 The Regents Of The University Of California Oxysterol compounds and the hedgehog pathway

Similar Documents

Publication Publication Date Title
JP2009512422A5 (https=)
JP2006503819A5 (https=)
Hegde et al. Effect of osteoporosis medications on fracture healing
Rutten et al. Low-intensity pulsed ultrasound increases bone volume, osteoid thickness and mineral apposition rate in the area of fracture healing in patients with a delayed union of the osteotomized fibula
US7897588B2 (en) Agents and methods for enhancing bone formation
Adachi et al. Management of corticosteroid-induced osteoporosis
Chen et al. The “three in one” bone repair strategy for osteoporotic fractures
Takayama et al. Low-intensity pulsed ultrasound stimulates osteogenic differentiation in ROS 17/2.8 cells
CA2643732A1 (en) Oxysterol compounds and the hedgehog pathway
US9532994B2 (en) Agents and methods for enhancing bone formation by oxysterols in combination with bone morphogenic proteins
CN101868245B (zh) 含有用于刺激成骨细胞分化的骨形成肽1(bfp1)的合成肽及含有上述合成肽的药物组合物
JP2015518493A5 (https=)
RU2014149153A (ru) Новый аналог оксистерола, oxy149, индуцирует остеогенез и сигнальный путь hedgehog и ингибирует липогенез
JP2015517493A5 (https=)
Roberts et al. Anabolic strategies to augment bone fracture healing
US20090202660A1 (en) Agents and Methods for Osteogenic Oxysterols Inhibition of Oxidative Stress on Osteogenic Cellular Differentiation
Yang et al. Graphene oxide-decorated microporous sulfonated polyetheretherketone for guiding osteoporotic bone regeneration
US20090220562A1 (en) Osteogenic and anti-adipogenic oxysterols
Tao et al. Parathyroid hormone (1–34) can reverse the negative effect of valproic acid on the osseointegration of titanium rods in ovariectomized rats
Jiang et al. The effects of hypoxia-inducible factor (HIF)-1α protein on bone regeneration during distraction osteogenesis: an animal study
Li et al. Perioperative glucocorticosteroid treatment delays early healing of a mandible wound by inhibiting osteogenic differentiation
Shan et al. Insulin promotes the bone formation capability of human dental pulp stem cells through attenuating the IIS/PI3K/AKT/mTOR pathway axis
Carvas et al. A single dose of zoledronic acid reverses the deleterious effects of glucocorticoids on titanium implant osseointegration
Liu et al. Different effects of Wnt/β-catenin activation and PTH activation in adult and aged male mice metaphyseal fracture healing
Olivares-Navarrete et al. Sex dependent regulation of osteoblast response to implant surface properties by systemic hormones